You have 9 free searches left this month | for more free features.

Hemangiopericytoma/solitary fibrous tumor

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fibrous Dysplasia, McCune Albright Syndrome Trial in Leiden (Denosumab 120 Mg/1.7 Ml Inj, Placebo)

Recruiting
  • Fibrous Dysplasia
  • McCune Albright Syndrome
  • Denosumab 120 Mg/1.7 Ml Inj
  • Placebo
  • Leiden, Netherlands
    Leiden University Medical Center
Jul 20, 2023

Biliary Stones Trial in Worldwide (DSC, ERC)

Recruiting
  • Biliary Stones
  • DSC
  • ERC
  • Stanford, California
  • +7 more
Aug 17, 2022

Contributing Factors of Solitary Drinking Among Adolescents and

Not yet recruiting
  • Alcohol Drinking
  • Alcohol Use Disorder
  • questionnaire with interview
  • (no location specified)
Jun 15, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

Recruiting
  • Locally Advanced Solid Tumors
  • +3 more
  • Oral repotrectinib (TPX-0005)
  • Los Angeles, California
  • +27 more
Aug 9, 2022

GERD Trial in Cairo (Band Ligation)

Not yet recruiting
  • GERD
  • Band Ligation
  • Cairo, Egypt
    Endoscopy Unit Cairo University
Nov 8, 2023

PRP, Losartan, Muscle Injury Trial (Autologous platelets rich plasma, Autologous platelets rich plasma + oral LOSARTAN

Completed
  • PRP
  • +3 more
  • Autologous platelets rich plasma
  • Autologous platelets rich plasma + oral LOSARTAN administration
  • (no location specified)
Apr 12, 2023

Lung; Node Trial in Zurich (Forceps biopsy and cryobiopsy)

Active, not recruiting
  • Lung; Node
  • Forceps biopsy and cryobiopsy
  • Zurich, Switzerland
    University hospital Zurich
Jul 12, 2022

Plasmacytoma Trial in São Paulo (SBRT)

Terminated
  • Plasmacytoma
  • SBRT
  • São Paulo, Sao Paulo, Brazil
    Sao Paulo Cancer Institute
Mar 28, 2022

Thuflep/SOLEP : Initial Experience and Results of Prostate Laser

Completed
  • Prostate Hyperplasia
    • Rouen, France
      Clinique Saint Hilaire
    Mar 8, 2022

    Conscious Sedation Trial in Zagazig (dexmedetomidine- ketamine, dexmedetomidine- propofol)

    Recruiting
    • Conscious Sedation
    • dexmedetomidine- ketamine
    • dexmedetomidine- propofol
    • Zagazig, Egypt
      Zagazig University Hospitsals
    Dec 13, 2022

    Coronary Artery Disease (CAD) Trial in Worldwide (Evolocumab, Placebo, Statin therapy)

    Completed
    • Coronary Artery Disease (CAD)
    • Los Angeles, California
    • +32 more
    Apr 7, 2022

    Dissection of the Superior Mesenteric Artery

    Recruiting
    • Dissection of the Superior Mesenteric Artery
    • Observe the prognosis after stent implantation
    • Hangzhou, Zhejiang, China
      First Affiliated Hospital of Zhejiang University
    Dec 27, 2021

    Thyroid Nodule, Toxic or With Hyperthyroidism, Autonomous Thyroid Function, Thyroid Nodule; Hyperthyroidism Trial in Arnhem,

    Recruiting
    • Thyroid Nodule, Toxic or With Hyperthyroidism
    • +5 more
    • Radiofrequency ablation
    • Radioactive iodine
    • Arnhem, Gelderland, Netherlands
    • +1 more
    Dec 2, 2021

    Tethered Cord, Tethered Cord Syndrome, Occult Spina Bifida Trial in New York (Release of filum terminale)

    Recruiting
    • Tethered Cord
    • +3 more
    • Release of filum terminale
    • New York, New York
      Weill Cornell Medicine
    Jul 15, 2022

    Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,

    Not yet recruiting
    • Carcinoma
    • +8 more
    • Hepatic arterial infusion chemotherapy
    • +2 more
    • Guangzhou, Guangdong, China
      Lei Zhang
    Sep 22, 2021

    End Stage Renal Disease Trial in Lexington (Tacrolimus, Envarsus XR)

    Recruiting
    • End Stage Renal Disease
    • Lexington, Kentucky
      University of Kentucky Transplant Center
    Mar 11, 2022

    Df-Life : Quality of Life in Patients With Fibrous Dysplasia

    Not yet recruiting
    • Fibrous Dysplasia
    • FD qualitative study on quality of life
    • FD quantitative sudy on quality of life and olfaction.
    • Lyon, France
      Edouard Herriot Hospital - rheumatology
    Nov 9, 2022

    Sarcoma Trial in United Kingdom (radiotherapy)

    Completed
    • Sarcoma
    • radiotherapy
    • Birmingham, England, United Kingdom
    • +5 more
    Mar 17, 2021

    Bone Diseases, Pain Trial run by the NIDCR (Denosumab)

    Active, not recruiting
    • Bone Diseases
    • Pain
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 17, 2022

    Progressive Disease of Corneae Trial in Pristina (ReLex-smile)

    Enrolling by invitation
    • Progressive Disease of Corneae
    • ReLex-smile
    • Pristina, Kosovo
      Eye Hospital Pristina
    Mar 21, 2022

    Solitary Osseous Plasmacytoma Trial in United States (ixazomib, lenalidomide, dexamethasone)

    Active, not recruiting
    • Solitary Osseous Plasmacytoma
    • Anchorage, Alaska
    • +387 more
    Aug 16, 2021

    Fibrous Dysplasia of Bone.

    Completed
    • Fibrous Dysplasia of Bone
    • McCune Albright Syndrome
    • Evaluation and analysis of clinical data
    • Lyon, France
      rheumatology department, hopital Edouard Herriot
    Jun 16, 2022

    SARS-Cov-2 Induced Pulmonary Fibrosis Trial in Paris (Nintedanib 150 MG [Ofev], Placebo)

    Recruiting
    • SARS-Cov-2 Induced Pulmonary Fibrosis
    • Nintedanib 150 MG [Ofev]
    • Placebo
    • Paris, France
      Pneumologie
    May 2, 2022

    Postoperative Atrial Fibrillation Trial (Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days

    Recruiting
    • Postoperative Atrial Fibrillation
    • Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative
    • No-intervention.
    • Odense, Denmark
      Odense University Hospital
    Sep 30, 2022

    Hepatocellular Carcinoma, Portal Vein Tumour Thrombosis Trial in Canada (Neoadjuvant)

    Recruiting
    • Hepatocellular Carcinoma
    • Portal Vein Tumour Thrombosis
    • Neoadjuvant
    • Calgary, Alberta, Canada
    • +6 more
    Oct 18, 2022